Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis

Eur J Cancer. 2021 Sep:155:25-27. doi: 10.1016/j.ejca.2021.06.031. Epub 2021 Jul 29.
No abstract available

Keywords: Dermatomyositis; Hepatocarcinoma; Immune checkpoint inhibitors; Myasthenia gravis; Paraneoplastic syndrome.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / pharmacology
  • Dermatomyositis / chemically induced*
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Male

Substances

  • Antibodies, Monoclonal
  • Immune Checkpoint Inhibitors
  • durvalumab